Top Markets
#1 Ontology Gas Ontology Gas +45.07%
#2 Anvil Anvil +19.32%
#3 ETHGas ETHGas +19.07%
#4 Status Status +18.81%
#5 The Black Bull The Black Bull +17.02%
#6 Geodnet Geodnet +16.47%
#7 Fake World Assets Fake World Assets +13.85%
#8 Derive Derive +10.68%
#9 Ontology Ontology +9.78%
#10 Gas Gas +9.27%
Coin of the day
Ontology Gas Ontology Gas
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Nuo Therapeutics, Inc. Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc.

AURX
Rangering i aksjer #25545
Nuo Therapeutics, Inc. operates as a regenerative medicine company,... Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds. Established in Houston, Texas, in 1998, the company underwent a name change from Cytomedix, Inc. to Nuo Therapeutics, Inc. in November 2014.
Aksjekurs
$1.00
Sist synkronisert: 2026-08-19
Markedsverdi
$48.41M
Endring (1 dag)
0.00%
Endring (1 år)
-41.86%
Land
US
Handel Nuo Therapeutics, Inc. (AURX)

Kategori

Healthcare
Inntekter for Nuo Therapeutics, Inc. (AURX)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Nuo Therapeutics, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Nuo Therapeutics, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US